239 related articles for article (PubMed ID: 33327501)
1. The Impact of Low-Level Iron Supplements on the Faecal Microbiota of Irritable Bowel Syndrome and Healthy Donors Using In Vitro Batch Cultures.
Poveda C; Pereira DIA; Lewis M; Walton GE
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33327501
[TBL] [Abstract][Full Text] [Related]
2. Effect of breadmaking process on in vitro gut microbiota parameters in irritable bowel syndrome.
Costabile A; Santarelli S; Claus SP; Sanderson J; Hudspith BN; Brostoff J; Ward JL; Lovegrove A; Shewry PR; Jones HE; Whitley AM; Gibson GR
PLoS One; 2014; 9(10):e111225. PubMed ID: 25356771
[TBL] [Abstract][Full Text] [Related]
3. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
[TBL] [Abstract][Full Text] [Related]
5. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
6. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
[TBL] [Abstract][Full Text] [Related]
9. The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome.
Shankar V; Homer D; Rigsbee L; Khamis HJ; Michail S; Raymer M; Reo NV; Paliy O
ISME J; 2015 Aug; 9(8):1899-903. PubMed ID: 25635640
[TBL] [Abstract][Full Text] [Related]
10. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
[TBL] [Abstract][Full Text] [Related]
11. Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome.
Holster S; Repsilber D; Geng D; Hyötyläinen T; Salonen A; Lindqvist CM; Rajan SK; de Vos WM; Brummer RJ; König J
Benef Microbes; 2021 Feb; 12(1):17-30. PubMed ID: 33350360
[TBL] [Abstract][Full Text] [Related]
12. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.
Liu S; Si C; Yu Y; Zhao G; Chen L; Zhao Y; Zhang Z; Li H; Chen Y; Min L; Zhang S; Zhu S
Front Cell Infect Microbiol; 2019; 9():178. PubMed ID: 31192167
[TBL] [Abstract][Full Text] [Related]
14. A decrease in iron availability to human gut microbiome reduces the growth of potentially pathogenic gut bacteria; an in vitro colonic fermentation study.
Parmanand BA; Kellingray L; Le Gall G; Basit AW; Fairweather-Tait S; Narbad A
J Nutr Biochem; 2019 May; 67():20-27. PubMed ID: 30831460
[TBL] [Abstract][Full Text] [Related]
15. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
16. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
[No Abstract] [Full Text] [Related]
17. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
19. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.
Rangel I; Sundin J; Fuentes S; Repsilber D; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Nov; 42(10):1211-21. PubMed ID: 26376728
[TBL] [Abstract][Full Text] [Related]
20. Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects.
Chung CS; Chang PF; Liao CH; Lee TH; Chen Y; Lee YC; Wu MS; Wang HP; Ni YH
Scand J Gastroenterol; 2016; 51(4):410-9. PubMed ID: 26595305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
